Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study

Journal of the American Academy of Dermatology

Volumn 80, Issue 4, 2019, Pages 1022-1028

  van Delft, Lieke C J ^a,b   Nelemans, Patty J ^c   Jansen, Maud H E ^a,b   Arits, Aimee H M M ^a,b,d   Roozeboom, Marieke H ^e   Hamid, Myrurgia A ^a   Mosterd, Klara ^a,b   Kelleners Smeets, Nicole W J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e ELKERLIEK HOSPITAL   (Netherlands)

Author keywords

5 fluorouracil; basal cell carcinoma; histologic subtype; imiquimod; MAL PDT; misclassification; noninvasive therapy; sampling error; superficial; transformation

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; FLUOROURACIL; IMIQUIMOD; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPERFICIAL BASAL CELL CARCINOMA; TREATMENT FAILURE; AGED; ANALOGS AND DERIVATIVES; BASAL CELL CARCINOMA; EQUIVALENCE TRIAL (TOPIC); PATHOLOGY; PHOTOCHEMOTHERAPY; SKIN TUMOR;

AGED; AMINOLEVULINIC ACID; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; EQUIVALENCE TRIALS AS TOPIC; FEMALE; FLUOROURACIL; HUMANS; IMIQUIMOD; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT FAILURE;

EID: 85061451956     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2018.12.028     Document Type: Article

References (39)

1. Clark, C.M., Furniss, M., Mackay-Wiggan, J.M., Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol 15 (2014), 197–216.
2. Williams, H.C., Bath-Hextall, F., Ozolins, M., et al. Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial. J Invest Dermatol 137 (2017), 614–619.
3. Morton, C.A., Szeimies, R.M., Sidoroff, A., Braathen, L.R., European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 27 (2013), 536–544.
4. Trakatelli, M., Morton, C., Nagore, E., et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol 24 (2014), 312–329.
5. Work Group, Invited Reviewers, Kim, J.Y.S., Kozlow, J.H., Mittal, B., et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 78 (2018), 540–559.
6. Roozeboom, M.H., Arits, A.H., Nelemans, P.J., Kelleners-Smeets, N.W., Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 167 (2012), 733–756.
7. Arits, A.H., Mosterd, K., Essers, B.A., et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 14 (2013), 647–654.
8. Kelleners-Smeets, N.W., Mosterd, K., Nelemans, P.J., Treatment of low-risk basal cell carcinoma. J Invest Dermatol 137 (2017), 539–540.
9. Fiechter, S., Skaria, A., Nievergelt, H., Anex, R., Borradori, L., Parmentier, L., Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes. Dermatology 224 (2012), 346–351.
10. Skaria, A.M., Facial basal cell carcinomas recurring after imiquimod therapy. Dermatology 226 (2013), 13–14.
11. Xiong, M.Y., Korgavkar, K., Digiovanna, J.J., et al. Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial. JAMA Dermatol 150 (2014), 332–334.
12. Bernabo JL, Lopez Navarro N, Dominguez G, Zmudzinska M, Herrera Ceballos E. Histological study of basal cell carcinomas recurring after photodynamic therapy: a comparative analysis against its primary tumors [abstract]. Presented at the 33rd Nordic Congress of Dermatology and Venereology, April 27-29, Trondheim, Norway.
13. Hoogedoorn, L., Hendriks, J.C., Knuiman, G.J., et al. Treatment failure in superficial basal cell carcinoma following treatment with photodynamic therapy: is this a result of underdiagnosis?. J Eur Acad Dermatol Venereol 31 (2017), e50–e52.
14. Stamell Ruiz, E., Cohen, J.L., Friedman, A., Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?. J Drugs Dermatol, 14, 2015, 3.
15. Cohen, P.R., Schulze, K.E., Nelson, B.R., Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg 32 (2006), 542–551.
16. Jansen, M.H.E., Mosterd, K., Arits, A.H.M.M., et al. Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma. J Invest Dermatol 138 (2018), 527–533.
17. Roozeboom, M.H., Arits, A.H.M.M., Mosterd, K., Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial. J Invest Dermatol 136 (2016), 1568–1574.
18. Jansen, M.H.E., Koekelkoren, F.H.J., Nelemans, P.J., et al. Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma. J Am Acad Dermatol 79 (2018), 961–964.
19. Devine, C., Srinivasan, B., Sayan, A., Ilankovan, V., Epidemiology of basal cell carcinoma: a 10-year comparative study. Br J Oral Maxillofac Surg 56 (2018), 101–106.
20. Arits, A.H., Schlangen, M.H., Nelemans, P.J., Kelleners-Smeets, N.W., Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol 25 (2011), 565–569.
21. Betti, R., Radaelli, G., Bombonato, C., Crosti, C., Cerri, A., Menni, S., Anatomic location of Basal cell carcinomas may favor certain histologic subtypes. J Cutan Med Surg 14 (2010), 298–302.
22. Mohs, F.E., Jones, D.L., Bloom, R.F., Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma. Arch Dermatol 114 (1978), 1021–1022.
23. Boulinguez, S., Grison-Tabone, C., Lamant, L., et al. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol 151 (2004), 623–626.
24. Bartoš V., Pokorný D., Zacharová O., et al. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Pannonica Adriat 20 (2011), 67–75.
25. Lang, P.G. Jr., Maize, J.C., Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 14:2 pt 1 (1986), 186–196.
26. van Loo, E., Mosterd, K., Krekels, G.A., et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 50 (2014), 3011–3020.
27. Lanoue, J., Goldenberg, G., Basal cell carcinoma: a comprehensive review of existing and emerging nonsurgical therapies. J Clin Aesthet Dermatol 9 (2016), 26–36.
28. Eigentler, T.K., Kamin, A., Weide, B.M., et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 57 (2007), 616–621.
29. Shumack, S., Robinson, J., Kossard, S., et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 138 (2002), 1165–1171.
30. Bath-Hextall, F., Ozolins, M., Armstrong, S.J., et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 15 (2014), 96–105.
31. Vidal, D., Matias-Guiu, X., Alomar, A., Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Arch Dermatol 143 (2007), 266–268.
32. Roozeboom, M.H., Mosterd, K., Winnepenninckx, V.J., Nelemans, P.J., Kelleners-Smeets, N.W., Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol 27 (2013), 894–898.
33. Haws, A.L., Rojano, R., Tahan, S.R., Phung, T.L., Accuracy of biopsy sampling for subtyping basal cell carcinoma. J Am Acad Dermatol 66 (2012), 106–111.
34. Wolberink, E.A., Pasch, M.C., Zeiler, M., van Erp, P.E., Gerritsen, M.J., High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J Eur Acad Dermatol Venereol 27 (2013), 985–989.
35. Kamyab-Hesari, K., Seirafi, H., Naraghi, Z.S., et al. Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma. J Eur Acad Dermatol Venereol 28 (2014), 250–253.
36. Sun, M.T., Wu, A., Huilgol, S.C., Selva, D., Accuracy of biopsy in subtyping periocular basal cell carcinoma. Ophthalmic Plast Reconstr Surg 31 (2015), 449–451.
37. Nguyen, K.P., Knuiman, G.J., van Erp, P.E., Blokx, W.A., Peppelman, M., Gerritsen, M.P., Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes. J Am Acad Dermatol 76 (2017), 351–353.e3.
38. Kadouch, D.J., Leeflang, M.M., Elshot, Y.S., et al. Diagnostic accuracy of confocal microscopy imaging vss punch biopsy for diagnosing and subtyping basal cell carcinoma. J Eur Acad Dermatol Venereol 31 (2017), 1641–1648.
39. Kadouch, D.J., Schram, M.E., Leeflang, M.M., Limpens, J., Spuls, P.I., de Rie, M.A., In vivo confocal microscopy of basal cell carcinoma: a systematic review of diagnostic accuracy. J Eur Acad Dermatol Venereol 29 (2015), 1890–1897.